Please login to the form below

Not currently logged in
Email:
Password:

Alliance Pharma appoints two European country managers

Dr Philippe Pasdelou and Lars Börger join the UK-based specialty pharma firm

UK specialty company Alliance Pharma has appointed two new country managers.

Dr Philippe Pasdelou will manage operations in France, while Lars Börger will lead the company's teams in Germany, Switzerland and Austria.

At the same time the company announced its acquisition of three antimalarial drugs from AstraZeneca for £4.2m and up to £1m in future sales royalties.

The brands – Paludrine, Avoclor and Savarine – are sold predominately in the UK and France and are expected to generate approximately £1.1m per year to Alliance's balance sheet.

“We are delighted to add these important antimalarial brands to the Alliance portfolio, and at the same time to have appointed such highly experienced executives as Philippe Pasdelou and Lars Börger to spearhead our expansion in mainland Europe,” said John Dawson, chief executive of Alliance Pharma.

The company said both Pasdelou and Börger would initially focus on securing acquisition and in-licensing opportunities across Europe.

Börger was most recently licensing director at Grünenthal and has experience across a number of pharmaceutical and medical device companies, in both strategic and operational roles.

Meanwhile, Pasdelou has managed several pharmaceutical companies in France and other countries and his experience includes setting up a company with a similar business model to Alliance.

14th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics